{"transactions":[{"id":758842,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:05:36.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248249/ownership.xml","form_type":"4"}},{"id":858312,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":30072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":288517,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":30072},"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858311,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":258445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":258445,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":258445},"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858310,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":21330,"price":13.4288,"value":286436.304,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance-Based Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.52 USD; the price reported above reflects the weighted average sale price."}],"balance_after":328397,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858309,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":50557,"price":12.7865,"value":646447.0805,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance-Based Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $12.299 USD to $13.277 USD; the price reported above reflects the weighted average sale price."}],"balance_after":349727,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858308,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":200284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":400284,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":858307,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:30:44.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001194459-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000119445926000001/primarydocument.xml","form_type":"4"}},{"id":1127792,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:12:53.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080261/ownership.xml","form_type":"4"}},{"id":1344650,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T22:12:25.000Z","date":"2024-11-29","kind":"grant","planned":false,"acquired":true,"shares":18169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":94499,"source":{"system":"sec-edgar","filing":"0001415889-24-028153","document":"form4-12032024_101221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000141588924028153/form4-12032024_101221.xml","form_type":"4"}},{"id":1495280,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:31:39.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068038/ownership.xml","form_type":"4"}},{"id":1503430,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T20:33:35.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":16.98,"value":254700.0,"ownership":{"direct":true},"balance_after":76330,"source":{"system":"sec-edgar","filing":"0001415889-24-014279","document":"form4-05232024_080506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000141588924014279/form4-05232024_080506.xml","form_type":"4"}},{"id":1580647,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T20:32:22.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":16.3,"value":244500.0,"ownership":{"direct":true},"balance_after":61330,"source":{"system":"sec-edgar","filing":"0001415889-24-007635","document":"form4-03122024_080313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000141588924007635/form4-03122024_080313.xml","form_type":"4"}},{"id":1723575,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T22:33:24.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":20374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":46330,"source":{"system":"sec-edgar","filing":"0001415889-23-015780","document":"form4-12042023_101219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000141588923015780/form4-12042023_101219.xml","form_type":"4"}},{"id":1839816,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-07-03T13:15:07.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":48128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":48128,"derivative":{"exercise_price":10.56,"expiration_date":"2033-06-29","underlying":"Class A Ordinary Shares","underlying_shares":48128},"source":{"system":"sec-edgar","filing":"0001209191-23-040419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000120919123040419/doc4.xml","form_type":"4"}},{"id":2097965,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T22:10:49.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":18649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":25956,"source":{"system":"sec-edgar","filing":"0001415889-22-011980","document":"form4-12022022_101236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000141588922011980/form4-12022022_101236.xml","form_type":"4"}},{"id":2195789,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:44:45.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":837,"price":69.659,"value":58304.583,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":551176,"source":{"system":"sec-edgar","filing":"0001645113-22-000071","document":"wf-form4_165955946744367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000071/wf-form4_165955946744367.xml","form_type":"4"}},{"id":2208099,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2022-07-14T01:27:00.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":1514326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."}],"balance_after":1514326,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1514326},"source":{"system":"sec-edgar","filing":"0000950103-22-012366","document":"dp177040_4-doyle.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012366/dp177040_4-doyle.xml","form_type":"4"}},{"id":2208098,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2022-07-14T01:27:00.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":1514326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Class B Ordinary Share has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the Securities and Exchange Commission on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (\"ProKidney\") (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."}],"balance_after":1514326,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1514326},"source":{"system":"sec-edgar","filing":"0000950103-22-012366","document":"dp177040_4-doyle.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012366/dp177040_4-doyle.xml","form_type":"4"}},{"id":2220055,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-28T23:35:30.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."}],"balance_after":2500,"derivative":{"exercise_price":3.32,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-039688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919122039688/doc4.xml","form_type":"4"}},{"id":2341830,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2022-03-09T21:48:00.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2385,"price":70.1,"value":167188.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":552013,"source":{"system":"sec-edgar","filing":"0001645113-22-000024","document":"wf-form4_164686246214915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000024/wf-form4_164686246214915.xml","form_type":"4"}},{"id":2347773,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T23:21:15.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":14581,"price":80.59,"value":1175082.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options to buy 14,581 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":14581,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":14581},"source":{"system":"sec-edgar","filing":"0001645113-22-000018","document":"wf-form4_164669525357817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000018/wf-form4_164669525357817.xml","form_type":"4"}},{"id":2488393,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T22:11:05.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":7307,"source":{"system":"sec-edgar","filing":"0001179110-21-010527","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000117911021010527/edgar.xml","form_type":"4"}},{"id":2614847,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-08-04T21:01:25.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":995,"price":149.378,"value":148631.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":554398,"source":{"system":"sec-edgar","filing":"0001645113-21-000096","document":"wf-form4_162811081937813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000096/wf-form4_162811081937813.xml","form_type":"4"}},{"id":2667952,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:49:54.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 40,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-040687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919121040687/doc4.xml","form_type":"4"}},{"id":2748638,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":600,"price":216.694,"value":130016.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F22","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 600 shares in multiple trades at prices ranging from $216.57 to $216.79.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":555393,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748637,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":500,"price":214.665,"value":107332.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F21","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 500 shares in multiple trades at prices ranging from $213.99 to $214.91.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":555993,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748636,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1500,"price":213.347,"value":320020.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F20","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,500 shares in multiple trades at prices ranging from $212.95 to $213.72.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":556493,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748635,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":600,"price":211.276,"value":126765.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 600 shares in multiple trades at prices ranging from $211.18 to $211.38.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":557993,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748634,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":521,"price":210.181,"value":109504.301,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 521 shares in multiple trades at prices ranging from $209.81 to $210.66.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":558593,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748633,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":2200,"price":209.343,"value":460554.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,200 shares in multiple trades at prices ranging from $208.74 to $209.72.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":559114,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748632,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":4500,"price":207.804,"value":935118.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,500 shares in multiple trades at prices ranging from $207.20 to $208.20.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":561314,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748631,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1284,"price":206.352,"value":264955.968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,284 shares in multiple trades at prices ranging from $206.04 to $207.01.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":565814,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748630,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1600,"price":205.431,"value":328689.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,600 shares in multiple trades at prices ranging from $205.00 to $205.76.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":567098,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748629,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1972,"price":204.277,"value":402834.244,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,972 shares in multiple trades at prices ranging from $203.96 to $204.90.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":568698,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748628,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":2555,"price":203.253,"value":519311.415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,555 shares in multiple trades at prices ranging from $202.90 to $203.77.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":570670,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748627,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":4388,"price":202.158,"value":887069.304,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,388 shares in multiple trades at prices ranging from $201.85 to $202.74.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":573225,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748626,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":4125,"price":201.546,"value":831377.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,125 shares in multiple trades at prices ranging from $200.85 to $201.84.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":577613,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748625,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":4338,"price":199.713,"value":866354.994,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,338 shares in multiple trades at prices ranging from $199.50 to $200.30.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":581738,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748624,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":10563,"price":198.977,"value":2101794.051,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 10,563 shares in multiple trades at prices ranging from $198.49 to $199.43.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":586076,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748623,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":13612,"price":197.831,"value":2692875.572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 13,612 shares in multiple trades at prices ranging from $197.39 to $198.29.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":596639,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748622,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":24338,"price":197.003,"value":4794659.014,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 24,338 shares in multiple trades at prices ranging from $196.38 to $197.38.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":610251,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748621,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":8814,"price":196.073,"value":1728187.422,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 8,814 shares in multiple trades at prices ranging from $195.38 to $196.36.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":634589,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748620,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1600,"price":194.94,"value":311904.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,600 shares in multiple trades at prices ranging from $194.38 to $195.35.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":643403,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748619,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":2090,"price":193.571,"value":404563.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,090 shares in multiple trades at prices ranging from $193.15 to $194.06.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":645003,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748618,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1900,"price":192.524,"value":365795.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,900 shares in multiple trades at prices ranging from $192.00 to $193.00.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":647093,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2748617,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-15T22:29:14.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":1400,"price":191.263,"value":267768.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,400 shares in multiple trades at prices ranging from $191.00 to $191.95.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":648993,"source":{"system":"sec-edgar","filing":"0001645113-21-000056","document":"wf-form4_161852573844212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000056/wf-form4_161852573844212.xml","form_type":"4"}},{"id":2761291,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2021-04-02T20:14:43.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":9259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2019-03-31","underlying":"Ordinary Shares","underlying_shares":9259},"source":{"system":"sec-edgar","filing":"0001645113-21-000049","document":"wf-form4_161739444210734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000049/wf-form4_161739444210734.xml","form_type":"4"}},{"id":2761290,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-02T20:14:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":7928,"price":134.12,"value":1063303.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":650393,"source":{"system":"sec-edgar","filing":"0001645113-21-000049","document":"wf-form4_161739444210734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000049/wf-form4_161739444210734.xml","form_type":"4"}},{"id":2761289,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2021-04-02T20:14:43.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":9259,"price":125.25,"value":1159689.75,"ownership":{"direct":true},"balance_after":658321,"source":{"system":"sec-edgar","filing":"0001645113-21-000049","document":"wf-form4_161739444210734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000049/wf-form4_161739444210734.xml","form_type":"4"}},{"id":3071382,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-08-03T21:51:10.000Z","date":"2020-07-31","kind":"sale","acquired":false,"shares":896,"price":76.388,"value":68443.648,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":649062,"source":{"system":"sec-edgar","filing":"0001645113-20-000113","document":"wf-form4_159649143693903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000113/wf-form4_159649143693903.xml","form_type":"4"}},{"id":3111554,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T20:57:47.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. An additional option grant to purchase 20,000 shares of common stock  was granted to the Reporting Person at the discretion of the Company's board of directors for such Reporting Person's service as lead independent director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-036331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919120036331/doc4.xml","form_type":"4"}},{"id":3111871,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T07:53:46.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":14439,"price":5.65,"value":81580.35,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 10, 2021 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2021 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":14439,"derivative":{"exercise_price":5.65,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":14439},"source":{"system":"sec-edgar","filing":"0001494650-20-000068","document":"wf-form4_159196280835409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000149465020000068/wf-form4_159196280835409.xml","form_type":"4"}},{"id":3152757,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-12T20:13:29.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":31332,"price":63.728,"value":1996725.696,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on May 8, 2020.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":649958,"source":{"system":"sec-edgar","filing":"0001645113-20-000076","document":"wf-form4_158931439083079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000076/wf-form4_158931439083079.xml","form_type":"4"}},{"id":3154552,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-05-11T20:17:59.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":58767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-05-08","underlying":"Ordinary Shares","underlying_shares":58767},"source":{"system":"sec-edgar","filing":"0001645113-20-000074","document":"wf-form4_158922826177084.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000074/wf-form4_158922826177084.xml","form_type":"4"}},{"id":3154551,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Share Units","published_at":"2020-05-11T20:17:59.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":58767,"derivative":{"exercise_price":0,"exercise_date":"2020-05-07","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001645113-20-000074","document":"wf-form4_158922826177084.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000074/wf-form4_158922826177084.xml","form_type":"4"}},{"id":3154550,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-11T20:17:59.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":31903,"price":63.501,"value":2025872.403,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":681290,"source":{"system":"sec-edgar","filing":"0001645113-20-000074","document":"wf-form4_158922826177084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000074/wf-form4_158922826177084.xml","form_type":"4"}},{"id":3154549,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-11T20:17:59.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":58767,"price":63.84,"value":3751685.28,"ownership":{"direct":true},"balance_after":713193,"source":{"system":"sec-edgar","filing":"0001645113-20-000074","document":"wf-form4_158922826177084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000074/wf-form4_158922826177084.xml","form_type":"4"}},{"id":3154548,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-11T20:17:59.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":30993,"price":64.741,"value":2006517.813,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":654426,"source":{"system":"sec-edgar","filing":"0001645113-20-000074","document":"wf-form4_158922826177084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000074/wf-form4_158922826177084.xml","form_type":"4"}},{"id":3154547,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-11T20:17:59.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":58768,"price":64.77,"value":3806403.36,"ownership":{"direct":true},"balance_after":685419,"source":{"system":"sec-edgar","filing":"0001645113-20-000074","document":"wf-form4_158922826177084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000074/wf-form4_158922826177084.xml","form_type":"4"}},{"id":3158091,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-05-07T20:41:22.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":117535,"derivative":{"exercise_price":0,"exercise_date":"2020-05-06","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001645113-20-000071","document":"wf-form4_158888406331399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000071/wf-form4_158888406331399.xml","form_type":"4"}},{"id":3158090,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-05-07T20:41:22.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":176303,"derivative":{"exercise_price":0,"exercise_date":"2020-05-06","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001645113-20-000071","document":"wf-form4_158888406331399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000071/wf-form4_158888406331399.xml","form_type":"4"}},{"id":3158089,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-07T20:41:22.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":58768,"price":64.15,"value":3769967.2,"ownership":{"direct":true},"balance_after":626651,"source":{"system":"sec-edgar","filing":"0001645113-20-000071","document":"wf-form4_158888406331399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000071/wf-form4_158888406331399.xml","form_type":"4"}},{"id":3158088,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-07T20:41:22.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":29881,"price":64.27,"value":1920451.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":567883,"source":{"system":"sec-edgar","filing":"0001645113-20-000071","document":"wf-form4_158888406331399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000071/wf-form4_158888406331399.xml","form_type":"4"}},{"id":3158087,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-07T20:41:22.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":30283,"price":62.468,"value":1891718.444,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":597764,"source":{"system":"sec-edgar","filing":"0001645113-20-000071","document":"wf-form4_158888406331399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000071/wf-form4_158888406331399.xml","form_type":"4"}},{"id":3158086,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-07T20:41:22.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":58768,"price":61.4,"value":3608355.2,"ownership":{"direct":true},"balance_after":628047,"source":{"system":"sec-edgar","filing":"0001645113-20-000071","document":"wf-form4_158888406331399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000071/wf-form4_158888406331399.xml","form_type":"4"}},{"id":3159559,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-05-06T21:52:34.000Z","date":"2020-05-04","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":235071,"derivative":{"exercise_price":0,"exercise_date":"2020-05-04","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001645113-20-000070","document":"wf-form4_158880193641944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000070/wf-form4_158880193641944.xml","form_type":"4"}},{"id":3159558,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-05-06T21:52:34.000Z","date":"2020-05-04","kind":"exercise","acquired":true,"shares":58768,"price":60.48,"value":3554288.64,"ownership":{"direct":true},"balance_after":569279,"source":{"system":"sec-edgar","filing":"0001645113-20-000070","document":"wf-form4_158880193641944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000070/wf-form4_158880193641944.xml","form_type":"4"}},{"id":3217844,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Share Units","published_at":"2020-03-10T20:18:44.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":4320,"price":69.534,"value":300386.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on March 5, 2020.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":510511,"source":{"system":"sec-edgar","filing":"0001645113-20-000048","document":"wf-form4_158387150702220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000048/wf-form4_158387150702220.xml","form_type":"4"}},{"id":3238226,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-03-02T22:13:55.000Z","date":"2020-02-27","kind":"exercise","acquired":false,"shares":9259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":9259,"derivative":{"exercise_price":0,"exercise_date":"2019-02-27","underlying":"Ordinary Shares","underlying_shares":9259},"source":{"system":"sec-edgar","filing":"0001645113-20-000031","document":"wf-form4_158318721760895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000031/wf-form4_158318721760895.xml","form_type":"4"}},{"id":3238225,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-03-02T22:13:55.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":3893,"price":72.215,"value":281132.995,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":514831,"source":{"system":"sec-edgar","filing":"0001645113-20-000031","document":"wf-form4_158318721760895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000031/wf-form4_158318721760895.xml","form_type":"4"}},{"id":3238224,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-03-02T22:13:55.000Z","date":"2020-02-27","kind":"exercise","acquired":true,"shares":9259,"price":79.45,"value":735627.55,"ownership":{"direct":true},"balance_after":518724,"source":{"system":"sec-edgar","filing":"0001645113-20-000031","document":"wf-form4_158318721760895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000031/wf-form4_158318721760895.xml","form_type":"4"}},{"id":3305311,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-01-22T21:19:46.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":133777,"price":95,"value":12708815.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle."}],"balance_after":509465,"source":{"system":"sec-edgar","filing":"0001645113-20-000008","document":"wf-form4_157972796879829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000008/wf-form4_157972796879829.xml","form_type":"4"}},{"id":3358799,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-11-26T21:29:36.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":16223,"price":96.04,"value":1558056.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 25, 2019, Mr. Doyle sold 16,223 shares in multiple trades at prices ranging from $96.00 to $96.13.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":643242,"source":{"system":"sec-edgar","filing":"0001645113-19-000015","document":"wf-form4_157480375888975.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511319000015/wf-form4_157480375888975.xml","form_type":"4"}},{"id":3361358,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-11-22T21:22:40.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":700,"price":91.01,"value":63707.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle."}],"balance_after":659465,"source":{"system":"sec-edgar","filing":"0001645113-19-000011","document":"wf-form4_157445774481944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511319000011/wf-form4_157445774481944.xml","form_type":"4"}},{"id":3361357,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-11-22T21:22:40.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":149300,"price":90.3551,"value":13490016.43,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 20, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 149,300 shares in multiple trades at prices ranging from $90.00 to $91.00.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":660165,"source":{"system":"sec-edgar","filing":"0001645113-19-000011","document":"wf-form4_157445774481944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511319000011/wf-form4_157445774481944.xml","form_type":"4"}},{"id":3372947,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-11-13T21:31:57.000Z","date":"2019-11-12","kind":"sale","acquired":false,"shares":2100,"price":82.142,"value":172498.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 12, 2019, Mr. Doyle sold 2,100 shares in multiple trades at prices ranging from $82.08 to $82.24.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":809465,"source":{"system":"sec-edgar","filing":"0001645113-19-000005","document":"wf-form4_157368070239649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511319000005/wf-form4_157368070239649.xml","form_type":"4"}},{"id":3372946,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-11-13T21:31:57.000Z","date":"2019-11-12","kind":"sale","acquired":false,"shares":11118,"price":81.59,"value":907117.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 12, 2019, Mr. Doyle sold 11,118 shares in multiple trades at prices ranging from $81.07 to $82.07.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":811565,"source":{"system":"sec-edgar","filing":"0001645113-19-000005","document":"wf-form4_157368070239649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511319000005/wf-form4_157368070239649.xml","form_type":"4"}},{"id":3372945,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-11-13T21:31:57.000Z","date":"2019-11-11","kind":"sale","acquired":false,"shares":29782,"price":80.108,"value":2385776.456,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 11, 2019, Mr. Doyle sold 29,782 shares in multiple trades at prices ranging from $80.00 to $80.45.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":822683,"source":{"system":"sec-edgar","filing":"0001645113-19-000005","document":"wf-form4_157368070239649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511319000005/wf-form4_157368070239649.xml","form_type":"4"}},{"id":3450882,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-08-01T20:12:02.000Z","date":"2019-07-30","kind":"grant","acquired":true,"shares":10412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These equity awards were granted to Mr. Doyle in recognition of his accomplishments related to Medicare coverage and pricing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 10,412 ordinary shares will vest and become exercisable in equal installments on each of July 30, 2020, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":10412,"derivative":{"exercise_price":83.3,"expiration_date":"2029-07-30","underlying":"Ordinary Shares","underlying_shares":10412},"source":{"system":"sec-edgar","filing":"0001209191-19-044010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044010/doc4.xml","form_type":"4"}},{"id":3450881,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-08-01T20:12:02.000Z","date":"2019-07-30","kind":"grant","acquired":true,"shares":6002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These equity awards were granted to Mr. Doyle in recognition of his accomplishments related to Medicare coverage and pricing."},{"field":"shares","element":"transactionShares","label":"F2","text":"One-third of these restricted stock units are scheduled to vest on each of July 30, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates."}],"balance_after":852465,"source":{"system":"sec-edgar","filing":"0001209191-19-044010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119044010/doc4.xml","form_type":"4"}},{"id":3474501,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-01T20:43:54.000Z","date":"2019-06-27","kind":"purchase","acquired":true,"shares":3500,"price":5.5,"value":19250.0,"ownership":{"direct":true},"balance_after":26111,"source":{"system":"sec-edgar","filing":"0001209191-19-039748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919119039748/doc4.xml","form_type":"4"}},{"id":3491072,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-13T20:28:29.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 12, 2019 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.5,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-036792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919119036792/doc4.xml","form_type":"4"}},{"id":3495715,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-10T10:48:41.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":14439,"price":6.6,"value":95297.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 6, 2020 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2020 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":14439,"derivative":{"exercise_price":6.6,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":14439},"source":{"system":"sec-edgar","filing":"0001494650-19-000053","document":"wf-form4_156017810578834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000149465019000053/wf-form4_156017810578834.xml","form_type":"4"}},{"id":3504731,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-06-03T20:08:58.000Z","date":"2019-05-30","kind":"sale","acquired":false,"shares":48100,"price":53.067,"value":2552522.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 30, 2019, Mr. Doyle sold 48,100 shares in multiple trades at prices ranging from $53.00 to $53.42.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":846463,"source":{"system":"sec-edgar","filing":"0001209191-19-033865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119033865/doc4.xml","form_type":"4"}},{"id":3506113,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-31T21:39:27.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following May 31, 2019 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":5.21,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-033703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919119033703/doc4.xml","form_type":"4"}},{"id":3506429,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-31T20:12:50.000Z","date":"2019-05-29","kind":"sale","acquired":false,"shares":1900,"price":53.095,"value":100880.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 29, 2019, Mr. Doyle sold 1,900 shares in multiple trades at prices ranging from $53.00 to $53.24.  The price reported above reflects the weighted average sale price.  Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":894563,"source":{"system":"sec-edgar","filing":"0001209191-19-033631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119033631/doc4.xml","form_type":"4"}},{"id":3531583,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-10T20:13:02.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 35,000 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $71.34 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Doyle has been continuously employed by the Company through May 8, 2022."}],"balance_after":35000,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-08","underlying":"Ordinary Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-19-028879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028879/doc4.xml","form_type":"4"}},{"id":3531582,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-10T20:13:02.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":115060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 115,060 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $59.45 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Doyle has been continuously employed by the Company through May 8, 2022."}],"balance_after":115060,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-08","underlying":"Ordinary Shares","underlying_shares":115060},"source":{"system":"sec-edgar","filing":"0001209191-19-028879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028879/doc4.xml","form_type":"4"}},{"id":3531581,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-10T20:13:02.000Z","date":"2019-05-09","kind":"sale","acquired":false,"shares":31460,"price":47.374,"value":1490386.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of  Restricted Stock Units.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":896463,"source":{"system":"sec-edgar","filing":"0001209191-19-028879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028879/doc4.xml","form_type":"4"}},{"id":3533639,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-05-09T20:20:33.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":293839,"derivative":{"exercise_price":0,"exercise_date":"2019-05-08","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001209191-19-028476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028476/doc4.xml","form_type":"4"}},{"id":3533638,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-05-09T20:20:33.000Z","date":"2019-05-07","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":352607,"derivative":{"exercise_price":0,"exercise_date":"2019-05-07","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001209191-19-028476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028476/doc4.xml","form_type":"4"}},{"id":3533637,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-09T20:20:33.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":58768,"price":47.62,"value":2798532.16,"ownership":{"direct":true},"balance_after":927923,"source":{"system":"sec-edgar","filing":"0001209191-19-028476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028476/doc4.xml","form_type":"4"}},{"id":3533636,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-09T20:20:33.000Z","date":"2019-05-08","kind":"sale","acquired":false,"shares":32218,"price":47.521,"value":1531031.578,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":869155,"source":{"system":"sec-edgar","filing":"0001209191-19-028476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028476/doc4.xml","form_type":"4"}},{"id":3533635,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-09T20:20:33.000Z","date":"2019-05-07","kind":"exercise","acquired":true,"shares":58768,"price":48.92,"value":2874930.56,"ownership":{"direct":true},"balance_after":901373,"source":{"system":"sec-edgar","filing":"0001209191-19-028476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028476/doc4.xml","form_type":"4"}},{"id":3533634,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-09T20:20:33.000Z","date":"2019-05-07","kind":"sale","acquired":false,"shares":32098,"price":47.67,"value":1530111.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":842605,"source":{"system":"sec-edgar","filing":"0001209191-19-028476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119028476/doc4.xml","form_type":"4"}},{"id":3536504,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-05-07T20:28:35.000Z","date":"2019-05-06","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":411375,"derivative":{"exercise_price":0,"exercise_date":"2019-05-06","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001209191-19-027977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119027977/doc4.xml","form_type":"4"}},{"id":3536503,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-07T20:28:35.000Z","date":"2019-05-06","kind":"exercise","acquired":true,"shares":58768,"price":48.89,"value":2873167.52,"ownership":{"direct":true},"balance_after":874703,"source":{"system":"sec-edgar","filing":"0001209191-19-027977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119027977/doc4.xml","form_type":"4"}},{"id":3536502,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2019-05-07T20:28:35.000Z","date":"2019-05-06","kind":"sale","acquired":false,"shares":29038,"price":48.072,"value":1395914.736,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":815935,"source":{"system":"sec-edgar","filing":"0001209191-19-027977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119027977/doc4.xml","form_type":"4"}},{"id":3538118,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-05-06T21:48:45.000Z","date":"2019-05-03","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":470143,"derivative":{"exercise_price":0,"exercise_date":"2019-05-03","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001209191-19-027818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119027818/doc4.xml","form_type":"4"}},{"id":3538117,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2019-05-06T21:48:45.000Z","date":"2019-05-02","kind":"exercise","acquired":false,"shares":58768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":528911,"derivative":{"exercise_price":0,"exercise_date":"2019-05-02","underlying":"Ordinary Shares","underlying_shares":58768},"source":{"system":"sec-edgar","filing":"0001209191-19-027818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119027818/doc4.xml","form_type":"4"}}],"next_cursor":"2019-05-06T21:48:45.000000Z,3538117"}